New Studies Look To Support And Educate The LGBTQIA+ Community In Their Fertility Journeys
October 16, 2023 11:51 AM CT
Highlights From the American Society For Reproductive Medicine’s 2023 Scientific Congress
New Orleans, LA – Research presented at the American Society for Reproductive Medicine’s (ASRM) Scientific Congress is examining the impact of legislation on members of the LGBTQIA+ community undergoing fertility treatments and investigating the effects of gender-affirming hormone therapy on IVF outcomes.
Researchers in New York set out to evaluate the effect of the 2021 New York State Circular Letter No. 3 legislation on the utilization of IVF and co-IVF services by Same-Sex Female Couples (SSFC). The legislation in question expanded the definition of infertility to explicitly include LGBTQIA+ individuals and consequently supported greater insurance coverage of infertility services. Within one year of legislation enactment, researchers found fertility centers are beginning to see a higher uptake of IVF services amongst SSFC couples.
From researchers in Barcelona, Spain, a new study was conducted to evaluate if gender-affirming hormone therapy (GAHT) with testosterone administration prior to an ovarian stimulation in transmen patients affects the number and maturity of the oocytes recovered, the embryo development and the IVF clinical outcomes. As the number of individuals seeking sex hormone therapy due to gender dysphoria has been increasing in the last years, so has the transgender population in need of fertility treatment. Researchers concluded that since transgender men have an excellent response to ovarian stimulation even aer testosterone exposure, oocyte or embryo cryopreservation is a feasible and effective way to preserve their fertility for future biological parenting. These findings can help elaborate standardized protocols to guide professionals on the management of transgender persons through the course of fertility treatment.
- O-31 Estevez et al “Breaking Down Barriers For Same-Sex Female Couples Building Families: In Vitro Fertilization Utilization Since The Enactment Of 2021 New York State Legislation”
- ·O-36 Bargallo et al “Artificial Reproductive Technology In Transgender Men And Cisgender Women: Does Testosterone Administration Before Ovarian Stimulation Have An Impact On IVF Embryological And Clinical Outcomes?”
“As more and more LGBTQIA+ individuals seek to build families, it is vital that we have both the scientific know-how and social policies to support them,” stated Paula Amato, MD, incoming President of ASRM, “This kind of research moves us closer to our goals of equal access to quality reproductive health care for all people.”
To view these abstracts and more in full, please visit: https://www.fertstert.org/issue/S0015-0282(23)X0012-0
For almost a century, the American Society for Reproductive Medicine (ASRM) has been the global leader in multidisciplinary reproductive medicine research, ethical practice, and education. ASRM impacts reproductive care and science worldwide by creating funding opportunities for advancing reproduction research and discovery, by providing evidence-based education and public health information, and by advocating for reproductive health care professionals and the patients they serve. With members in more than 100 countries, the Society is headquartered in Washington, DC, with additional operations in Birmingham, AL. www.asrm.org
For media inquiries regarding this press release contact:
Sean Tipton
ASRM Chief Advocacy and Policy Officer
E: stipton@asrm.org
J. Benjamin Younger Office of Public Affairs
726 7th St. SE
Washington, DC 20003
Tel: (202) 863-2494
Fertility in the News

Doctors Group Launches Ad Campaign for Ohio Issue 1
ASRM announced the launch of an ad campaign throughout Ohio urging voters to select “Yes on Issue 1” when they head to the polls on November 7.

Dr. Paula Amato Sworn In As President Of The American Society For Reproductive Medicine
New Vice President and Board Members Announced
New Data Shows The Association Between Air Pollution And Miscarriage Risk
Research presented at ASRM 2023 examines the association between ambient air pollution and miscarriage.

New Research Focuses On The Need For DEI In Reproductive Medicine
New research delves into the challenges faced by underrepresented populations in accessing reproductive healthcare.
LGBTQIA
Find a Health Professional
